Dr. Stanley, formerly Executive Director of the Center for Biostatistics in AIDS Research (CBAR), continues to be involved with the design and analysis of pediatric HIV disease clinical trials. He was the senior statistician for the pediatric study (PACTG 338) that identified the current standard therapy for children with HIV disease in 2000. Since then he has been involved with this study and others regarding aspects of immunology, neuropsychology, pharmacology and growth.

As continuation of his activities during eight years (1982-1990) at the World Health Organization in Geneva and his part-time position there in 2000-2001, Dr. Stanley has been involved in the development and evaluation of national cancer control programs, national screening programs for cervical cancer, and programs for palliative care in Africa. He edited the 2002 WHO monograph on national cancer control programs and the 2004 WHO monograph on palliative care for patients with HIV/AIDS or cancer in five African countries: Ethiopia, South Africa, Tanzania, Uganda and Zimbabwe. In November of 2003, he chaired a WHO meeting on strengthening cancer control programs in Europe, that included 39 participants from 17 European countries, and more than 20 experts and representatives of international organizations in the field of cancer. 

Since 2004 Dr. Stanley has been teaching Stat 104, an introduction to quantitative methods in economics, to Harvard undergraduates at Harvard College in Cambridge.  More than 1,300 students have taken his course.  Associated with the teaching of this course he has been twice nominated for the Joseph R. Levenson Teaching Prize by the Harvard University Undergraduate Council, he has been awarded a Certificate of Distinction for Excellence in Teaching sponsored by the Office of the Dean of Undergraduate Academic Programs at Harvard University, and has been voted by the Harvard University Class of 2009 to be “One of their favorite professors.”

Ph.D., 1974, University of Florida